380 related articles for article (PubMed ID: 15141961)
1. Biochemical effects of low level exposure to soman vapour.
Bajgar J; Sevelová L; Krejcová G; Fusek J; Vachek J; Kassa J; Herink J; de Jong LP; Benschop H
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S4-7. PubMed ID: 15141961
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and behavioral effects of soman vapors in low concentrations.
Bajgar J; Sevelová L; Krejcová G; Fusek J; Vachek J; Kassa J; Herink J; de Jong LP; Benschop HP
Inhal Toxicol; 2004 Jul; 16(8):497-507. PubMed ID: 15204741
[TBL] [Abstract][Full Text] [Related]
3. Changes of cholinesterase activity in the erythrocytes, plasma, diaphragm, liver and various parts of the brain in the rabbit following transfusion of erythrocytes with soman inhibited acetylcholinesterase.
Kassa J; Bajgar J; Fusek J
Acta Medica (Hradec Kralove); 1997; 40(2):37-9. PubMed ID: 9389209
[TBL] [Abstract][Full Text] [Related]
4. Low level nose-only exposure to the nerve agent soman: toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs.
Benschop HP; Trap HC; Spruit HE; Van Der Wiel HJ; Langenberg JP; De Jong LP
Toxicol Appl Pharmacol; 1998 Dec; 153(2):179-85. PubMed ID: 9878589
[TBL] [Abstract][Full Text] [Related]
5. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
6. Assessment of low level whole-body soman vapor exposure in rats.
Genovese RF; Benton BJ; Johnson CC; Jakubowski EM
Neurotoxicol Teratol; 2009; 31(2):110-8. PubMed ID: 19026741
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
8. Relationship between plasmatic levels of sarin and cholinesterase inhibition in rats exposed to sarin vapors.
Sevelová L; Bajgar J; Bielavská M
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S80-2. PubMed ID: 15141989
[TBL] [Abstract][Full Text] [Related]
9. Acute respiratory toxicity following inhalation exposure to soman in guinea pigs.
Perkins MW; Pierre Z; Rezk P; Sabnekar P; Kabra K; Chanda S; Oguntayo S; Sciuto AM; Doctor BP; Nambiar MP
Toxicol Appl Pharmacol; 2010 Jun; 245(2):171-8. PubMed ID: 20206646
[TBL] [Abstract][Full Text] [Related]
10. Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Toxicol Lett; 2011 May; 202(3):203-8. PubMed ID: 21329748
[TBL] [Abstract][Full Text] [Related]
11. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor.
Langenberg JP; Spruit HE; van der Wiel HJ; Trap HC; Helmich RB; Bergers WW; van Helden HP; Benschop HP
Toxicol Appl Pharmacol; 1998 Jul; 151(1):79-87. PubMed ID: 9705889
[TBL] [Abstract][Full Text] [Related]
12. Inhibition and recovery of maternal and fetal cholinesterase enzymes following a single oral dose of chlorpyrifos in rats.
Ashry KM; Abu-Qare AW; Saleem FR; Hussein YA; Hamza SM; Kishk AM; Abou-Donia MB
Arch Toxicol; 2002 Feb; 76(1):30-9. PubMed ID: 11875622
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized delivery of oxime MMB-4 in combination with atropine sulfate protects against soman exposure in guinea pigs.
Perkins MW; Pierre Z; Sabnekar P; Sciuto AM; Song J; Soojhawon I; Oguntayo S; Doctor BP; Nambiar MP
Inhal Toxicol; 2012 Aug; 24(9):539-49. PubMed ID: 22860999
[TBL] [Abstract][Full Text] [Related]
14. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK
J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the therapeutic efficacy of some antimuscarinics against soman in vivo.
Lau WM; Lewis KJ; Dawson RM
J Appl Toxicol; 1996; 16(5):423-30. PubMed ID: 8889794
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of blood, peripheral, and central cholinesterases in beagle dogs following dietary exposure to chlorpyrifos.
Marable BR; Maurissen JP; Mattsson JL; Billington R
Regul Toxicol Pharmacol; 2007 Apr; 47(3):240-8. PubMed ID: 17141929
[TBL] [Abstract][Full Text] [Related]
17. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the effect of HI-6 oxime and its derivatives in combination with benactyzine on cholinergic and stress effects of soman in rats].
Kassa J
Ceska Slov Farm; 1996 May; 45(3):149-53. PubMed ID: 8696692
[TBL] [Abstract][Full Text] [Related]
19. Inhalation toxicity of soman vapor in non-anesthetized rats: a preliminary assessment of inhaled bronchodilator or steroid therapy.
Perkins MW; Wong B; Rodriguez A; Devorak JL; Alves DA; Murphy G; Sciuto AM
Chem Biol Interact; 2013 Dec; 206(3):452-61. PubMed ID: 23886498
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of human butyrylcholinesterase pretreatment followed by acute soman challenge in cynomolgus monkeys.
Sun W; Doctor BP; Lenz DE; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):428-30. PubMed ID: 18674756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
